Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingre Chushi Decoction is a traditional Chinese medicine (TCM) herbal formula developed by the Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University, based on the clinical experience of the renowned dermatologist Zhao Bingnan. It is primarily indicated for the treatment of herpes zoster (shingles), particularly the damp-heat syndrome type. The decoction works by clearing heat and removing dampness, which in modern pharmacological terms translates to anti-inflammatory, analgesic, and immunomodulatory activities. It aims to reduce blister formation, alleviate pain (neuralgia), and shorten the course of the disease by downregulating pro-inflammatory cytokines such as IL-6 and TNF-alpha. It is widely used in clinical practice in China, often as a complementary therapy alongside standard antiviral medications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qing re chu shi decoction.